Hmm, a couple of concerns building here.
Cash flows aren't that great and are being used up fairly rapidly.
-mgnt fee 2.2m
-perf fee 2.45m
-dividend 6.7m
-interest 3.6m
- the buyback chews up another 4.4m, although this is discretionary
-other expenses 2.4m
All on net revenue of 12m.
And that doesn't count that interest rates are going up (they were average 3.04% this FY but will more likely be 4-5% next FY on $125m of borrowings).
They also cashed out their interest rate hedges to bring in 1.9m so they won't be available from now on.
Full disclosure, I sold out after being a holder for several years. Needed money for school fees so not entirely about D2O
- Forums
- ASX - By Stock
- Ann: 2022 Annual Report
Hmm, a couple of concerns building here.Cash flows aren't that...
Featured News
Add D2O (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.42 |
Change
-0.030(2.07%) |
Mkt cap ! $222.1M |
Open | High | Low | Value | Volume |
$1.45 | $1.46 | $1.42 | $113.3K | 78.61K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | $1.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 15258 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 1.420 |
2 | 10011 | 1.415 |
3 | 11944 | 1.410 |
2 | 723 | 1.405 |
4 | 7752 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 15258 | 1 |
1.460 | 391 | 1 |
1.465 | 5177 | 1 |
1.470 | 750 | 1 |
1.475 | 24277 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.43 |
  |
Change
-0.030 ( 2.06 %) |
|||
Open | High | Low | Volume | ||
$1.46 | $1.46 | $1.43 | 18058 | ||
Last updated 15.44pm 06/05/2024 ? |
Featured News
D2O (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online